FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/03/050196 [Registered on: 01/03/2023] Trial Registered Prospectively
Last Modified On: 25/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Prospective Study 
Study Design  Other 
Public Title of Study   A clinical trial to predict non invasive ventilation failure in chronic obstructive pulmonary disease patients using ultrasonographic evaluation of diaphragm 
Scientific Title of Study   Diaphragmatic ultrasound in predicting non-invasive ventilation failure in chronic obstructive pulmonary disease patients: A prospective observational study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kanika Chaudhary 
Designation  Senior Resident 
Affiliation  Max Superspecialty hospital 
Address  MICU 2, 2nd floor Department of Critical Care Medicine Max Super-speciality Hospital Mussoorie Diversion Road Dehradun Uttarakhand-248001

Dehradun
UTTARANCHAL
248001
India 
Phone  8447992368  
Fax    
Email  kanikaten@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shantanu Belwal 
Designation  Principle Consultant and Head of Department 
Affiliation  Max Superspecialty hospital 
Address  MICU2, 2nd floor Department of Critical Care Medicine Max Super-speciality Hospital Mussoorie Diversion Road Dehradun Uttarakhand-248001

Dehradun
UTTARANCHAL
248001
India 
Phone  919997642020  
Fax    
Email  Belwalster@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kanika Chaudhary 
Designation  Senior Resident 
Affiliation  Max Superspecialty hospital 
Address  MICU2, 2nd floor Department of Critical Care Medicine Max Super-speciality Hospital Mussoorie Diversion Road Dehradun Uttarakhand-248001

Dehradun
UTTARANCHAL
248001
India 
Phone  8447992368  
Fax    
Email  kanikaten@gmail.com  
 
Source of Monetary or Material Support  
Medical ICU Department of Critical Care Medicine Max Super speciality Hospital Dehradun 
 
Primary Sponsor  
Name  Dr Kanika Chaudhary 
Address  MICU2, 2nd floor Department of Critical Care Medicine Max Super speciality Hospital Mussoorie Diversion Road Dehradun Uttarakhand-248001 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Arjun Lal Poptani  Max Super specialty Hospital Mussoorie Diversion Road Dehradun Uttarakhand 
Dr Shantanu Belwal  Max Super speciality Hospital Mussoorie Diversion Road Dehradun Uttarakhand 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kanika Chaudhary  Max Supe specialty Hospital, Dehradun  MICU 2, 2nd floor Department of Critical Care Medicine Max Super specialty Hospital Mussoorie Diversion Road Dehradun Uttarakhand-248001
Dehradun
UTTARANCHAL 
8447992368

kanikaten@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Max Super Speciality Hospital, Dehradun  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J441||Chronic obstructive pulmonary disease with (acute) exacerbation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  50.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  COPD patients of either gender having a respiratory rate> 30 breaths per minute, peripheral oxygen saturation (SpO2) <88% with oxygen therapy through a Venturi mask or Non-Rebreathing Mask and active use of accessory muscles of respiration or paradoxical abdominal breathing. 
 
ExclusionCriteria 
Details  1) Refusal of written informed consent
2) Mentally Retarded patients
3) Shock requiring vasopressors support
4) Acute pulmonary edema
5) Interstitial lung disease
6) Chest wall deformities
7) Previous diaphragmatic palsy
8) Papilledema
9) Pregnancy
10) Obesity (BMI>35 Kg/m2)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Other 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
To predict NIV failure
 
Assessment will be done at baseline,6,12 and 24 hours of NIV treatment 
 
Secondary Outcome  
Outcome  TimePoints 
ICU stay, hospital stay and in hospital mortality
 
Secondary outcome will be assessed till 1 month of hospital stay 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/03/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Non-Invasive Ventilation (NIV) failure rates are increasing nowadays in patients admitted with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Sonographic assessment of the diaphragm is a non-invasive method of estimating diaphragmatic excursion (DE), speed of contraction (DC), and diaphragmatic thickness fraction (DTF). With these parameters, we can predict NIV failure and prevent delayed endotracheal intubation but there are limited data summarizing their accuracy across multiple studies. We will be performing a prospective observational study to evaluate the diaphragm using the ultrasonographic measurement of DE, DC, and DTF to predict NIV failure in COPD patients 
Close